If your hair loss is at the front, the question is whether minoxidil has evidence there. The sources behind this site support a narrower answer than a plain yes or no. The two US men's labels we checked say the product is for the top of the scalp and is not intended for a receding hairline. The trials that tested minoxidil against a product without it are not tied to a part of the scalp in what we could read. Two small trials did count hair at the front, and neither had a group without minoxidil.
This page sets out what each of those sources says and where it stops. It is about adult men with gradual thinning. It does not grade hairlines or say what counts as receding, because our sources do not.
What the labels say about where to use it
A product label belongs to one product in one country. We checked four men's labels on 29 September 2026, two from the United States and two from the United Kingdom. On the question of where on the scalp the product goes, they are not written the same way. [1, 2, 3, 4]
Four men's labels, and what each says about area
US and UK products, checked on 29 September 2026.
| On the label | USMen's Rogaine Extra Strength5% solution | USMinoxidil 5% for men5% foam | UKRegaine for Men Extra Strength5% solution | UKRegaine for Men Extra Strength5% foam |
|---|---|---|---|---|
| For | Men 18 and over | Men 18 and over | Men aged 18 to 65 | Men aged 18 to 49 |
| Area | The top of the scalp | The top of the scalp | 1 mL spread over all the affected areas | 1 g, about half a capful, spread over all the affected areas |
| The hairline | Not intended for frontal baldness or a receding hairline | Not intended for frontal baldness or a receding hairline | No statement recorded in our notes | No statement recorded in our notes |
| No change? | Stop and ask a doctor at 4 months | Stop and ask a doctor at 4 months | Stop after one year | Stop at 16 weeks |
Each column is one product's own label, paraphrased. The UK cells show what our research recorded from those two labels. They are not a finding that the UK products are labelled for the hairline. [1, 2, 3, 4]
The US wording is plain. Both packs are for hair loss on the top of the scalp, the area that trial reports call the vertex and this site calls the crown. Both state that the product is not intended for frontal baldness or a receding hairline. [1, 2]
The two UK labels are written differently. Each gives one amount to spread over all the affected areas of the scalp, twice a day: 1 mL of solution or 1 g of foam. Our notes on those two labels record no sentence about the hairline, for or against. That describes what we extracted. The leaflet in the pack is the text that counts. [3, 4]

The amounts, the timings and the rest of the instructions are compared in the label table of the minoxidil profile. The page on how to use minoxidil goes through them step by step.
Where the trials counted hair
A hair trial does not count the whole head. It marks a small patch, called a target area, and counts the hairs inside it at the start and at the end. For a hairline, the first thing to know about a trial is where that patch was.
Four minoxidil trials in men, and where each counted hair
The first two tested minoxidil against a product without it. The last two measured the front of the scalp.
| Trial | Who, and for how long | What was compared | Where hair was counted |
|---|---|---|---|
| 5% foam | 352 men aged 18 to 49, for 16 weeks | Foam with minoxidil against the same foam without it | A marked target area. Our notes from the UK product information and the trial's summary do not record where on the scalp it was. |
| 5% solution | 393 men, for 48 weeks | 5% against 2%, and against the liquid without minoxidil | Not recorded in our notes from the published summary, which is all we could read. |
| By mouth against solution | 90 men aged 18 to 55, for 24 weeks | 5 mg by mouth once a day against 1 mL of 5% solution twice a day | The front of the scalp and the crown, reported separately. |
| Mixed solution | 60 men aged 18 to 40, for 24 weeks | 5% minoxidil alone, 0.25% finasteride alone, or both in one solution | Three areas of 1 cm²: the front, the front and temples, and the crown. |
Neither of the two trials that measured the front had a group without minoxidil to compare with. [4, 5, 6, 7, 8]
The foam trial gives the clearest figure for minoxidil: about 21 hairs gained per square centimetre in the target area after 16 weeks, against about 4 with the foam that contained no minoxidil. The solution trial found 5% better than 2% and better than the liquid without minoxidil over 48 weeks. Those two results, together with the label instructions, are what minoxidil's place in the top tier of our ranking rests on. In the sources we read, neither is tied to a named part of the scalp, so neither can be quoted as a result for the hairline. [4, 5, 6]
Tablets against solution, at the front and at the crown
One trial counted the front of the scalp and the crown separately. Ninety men with pattern hair loss diagnosed by a dermatologist were randomly given either a 5 mg capsule of minoxidil by mouth once a day or 1 mL of 5% solution twice a day. The men were enrolled with grades our sources record as 3V, 4V or 5V, without describing them. Sixty-eight completed the 24 weeks, 33 in the oral group and 35 in the solution group. The main measure was the density of terminal hairs, the thicker ones, at each of the two sites. [7]
By mouth against solution at 24 weeks: difference in thicker hairs, by area
Front of the scalp
5 mg by mouth against 5% solution. Above zero means more hair in the oral group.
+3.1 (−18.2 to +21.5)
Crown
5 mg by mouth against 5% solution. Above zero means more hair in the oral group.
+23.4 (−0.3 to +43)
The dot is the measured difference and the bar is the range the true difference plausibly sits in. When the bar crosses zero, the trial did not show a difference. That is not the same as proving the two options are equal. One trial, with hair counts from 68 men. It was paid for by a research grant from FUNADERM, and the report states that the funder had no role in running, analysing or publishing it. [7]
At the front the measured difference was small. The oral group was ahead by 3.1 hairs per square centimetre, with a plausible range from 18.2 fewer to 21.5 more. At the crown the oral group was ahead by 23.4, with a range from 0.3 fewer to 43.0 more. Neither range excludes zero, so minoxidil by mouth was not shown to be better at either site, and neither is narrow enough to call the two forms equal. Photographs favoured the oral group as a secondary result, and that result was for the crown. [7]
For a hairline, this trial answers a small question and leaves the large one open. Every man in it was using minoxidil in one form or the other. So it can say that swallowing the medicine was not shown to do more at the front than applying it. It cannot say how much hair either form added at the front compared with using nothing. The front of the scalp is also the trial's own measuring site: our notes do not record how close to the hairline it sat. [7] The page on oral minoxidil goes through this trial in full, with its side effects and its drop-outs.
One small trial that reported the front, the temples and the crown
A trial in New Delhi is the only minoxidil trial we read that reports a count for the front and temples as a separate area. Sixty men aged 18 to 40 were randomly put into three groups of 20: 5% minoxidil alone, 0.25% finasteride alone, or both in one solution. Each man applied 1 mL twice a day for 24 weeks, and nobody dropped out. Hairs were counted by hand in an area of 1 cm² at each of three sites. [8]
In the 20 men who used 5% minoxidil alone, the printed average count rose over 24 weeks by 9.25 hairs per cm² at the front, 7.25 at the front and temples and 6.8 at the crown. The trial was open, hairs were counted by hand and there was no group without treatment, so these rises cannot be credited to minoxidil. The paper's tables also contain inconsistencies that our research did not resolve. [8]
The same trial also compared the mixed solution with minoxidil alone, area by area. The mix was significantly ahead on two of six measures: all hairs at the front and temples, and thicker hairs at the front. The page on minoxidil and finasteride together sets out that table. [8]
What that leaves for minoxidil at the hairline
Two statements are true at the same time, and neither cancels the other.
The evidence at the hairline is thin
We found no trial showing that it fails there
So in the sources we read the answer is not established, in either direction. A claim that minoxidil is proven to restore a hairline goes beyond these sources, and so does a claim that it is proven not to work there. What they do support is that minoxidil applied to the scalp raised hair counts in the measured area in men with pattern hair loss, and that the labels tie the benefit to continued use. [4, 6, 3, 1]
Finasteride, dutasteride and the front of the scalp
The same question can be put to the other options in our comparison of ingredients. The answer is similar: the largest trials were built around the crown.
Finasteride 1 mg tablets
Trials in men with crown thinningThe US label summarises two trials in 1,553 men with thinning at the crown. After 12 months the men on finasteride had 107 more hairs than the men on placebo in the measured patch, an area of 5.1 cm². Our research extracted only that part of the label. It did not extract what the label reports for other areas of the scalp, so this page gives no finasteride result for the front. [10]Finasteride trial resultsFinasteride applied to the scalp
One spray trial, one small solution groupThe trial of the finasteride spray enrolled men aged 18 to 40 with hair loss at the crown and counted hairs in a target area of 1 cm². In the New Delhi trial, the 20 men who used a 0.25% finasteride solution alone gained an average of 7.85 hairs per cm² at the front, 7.45 at the front and temples and 6.75 at the crown, again with no untreated group. [11, 8]Finasteride spray compared with the tabletDutasteride 0.5 mg capsules
Counted at the crownThe trial that compared dutasteride with finasteride and placebo, in 917 men over 24 weeks, counted hairs inside a circle 2.54 cm across at the crown. Its entry criteria, as our research recorded them, were Norwood grade III vertex, IV or V, with the anterior forms of grades IV and V excluded. Our sources name those grades without describing them. The trial was funded by GSK. [12]Dutasteride trial resultsSaw palmetto extract
Front and back added togetherOne trial of a named extract, in 60 adults of whom 30 were men, counted thicker hairs in two areas of 1 cm², one at the front and one at the back, and reported the two added together. [13, 14] At 180 days the front area on its own did not show a difference from placebo. [13]Saw palmetto trials
A trial built around the crown does not show that a treatment fails at the front. It shows that the front was not what the trial set out to measure.
None of this makes one option the better choice for a hairline. Finasteride and dutasteride are prescription medicines with warnings of their own, set out in the finasteride profile and on the page about finasteride side effects.
Does a receding hairline fit this comparison
Yes, with a condition. Male pattern hair loss is gradual thinning at the hairline or the crown, and an adult man with gradual thinning at the hairline is who the main guide to male pattern hair loss and the ranking are written for. [15] The pattern does not confirm the cause.
Sudden shedding, distinct patches, or a scalp that is painful, red or sore come before any product comparison. The page on types of hair loss in men sets out those signs and where each one leads, and the hair questionnaire points to the relevant page in a few questions. Neither can identify a cause.
If nothing has changed by the review point
Each label sets a point at which to stop if there has been no improvement. The four do not agree, so the rule that applies is the one on the pack in use. [3, 4, 1, 2] The foam and liquid comparison puts the four review points on one timeline.
The review point on each men's label
What the label says to do if there has been no improvement.
- US solution and US foam
- 4 monthsStop and ask a doctor if there is no regrowth.
- UK foam
- 16 weeksStop if there has been no improvement.
- UK solution
- One yearStop if there has been no improvement.
The labels expect the first signs after about two months, and the US labels add that some men need at least four. [3, 4, 1, 2]
These rules are written for the use each label describes. For the two US packs that is the top of the scalp, and the four-month rule belongs to that use. It is still the instruction on the pack, and what it says to do is ask a doctor. All four labels also say that treatment has to continue to keep any regrowth. [3, 4, 1, 2]

Photos taken in the same light, at the same hair length and from the same angle make the comparison at the review point less of an impression. The minoxidil profile has more on keeping track and on how long it takes.
What is not known
- How much hair minoxidil adds at the hairline compared with using nothing. We found no result against a product without minoxidil that our sources tie to the hairline.
- Whether the front responds differently from the crown. No trial we read tested one area against the other.
- Whether foam, solution and tablets differ at the hairline. Minoxidil by mouth was not shown to beat the solution at the front, and the foam trial is not reported by area in what we read.
- Why the US labels leave out the hairline. Our sources record the wording, not the reasoning.
- What happens at the front after 24 weeks, or after stopping. The two trials that measured there ended at 24 weeks.
- Whether finasteride tablets or dutasteride capsules change a hairline. Our research extracted only the crown results for both, so this page cannot answer it.
Where to go next
For the full picture of minoxidil, including side effects, cost and what happens when it is stopped, the profile is the place to start. If the hair loss is not gradual, or the scalp is sore, the types page comes first. How we handle evidence, and why we stop where the sources stop, is on the methodology page.
Minoxidil: the full profileTrial numbers, the four label instructions, side effects, cost and what happens if you stop. Minoxidil vs finasterideThe two options in the top tier of the ranking, compared on the same criteria. Types of hair loss in menWhich changes fit the comparison, and which need an assessment first.